From: HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia
Gene, genotype and allele | HPV+/− n( %) | Odds ratio | P-Value | Deviation from HWE | ||
---|---|---|---|---|---|---|
Cases | Controls | (95% CI) | Â | Expected | ||
(HPV+) (n= 82) | (HPV-) (n= 18) | Cases | Controls | |||
XRCC1 codon 399 G>A Arg/Gln (rs25487) | ||||||
Genotype | Â | Â | Â | Â | Â | Â |
G/G | 42 (51) | 11 (61) | Â | Â | 37.56 | 10.89 |
G/A | 27 (33) | 6 (33) | 1.18 (0.39-3.56) | 0.77 | 35.87 | 6.22 |
A/A | 13 (16) | 1 (6) | 3.41 (0.40-28.93) | 0.24 | 8.56 | 0.89 |
G/A+A/A | 40 (49) | 7 (39) | 1.49 (0.53-4.24) | 0.45 | Â | Â |
Allele | Â | Â | Â | Â | Â | Â |
G | 111 (68) | 28 (78) | Â | Â | Â | Â |
A | 53 (32) | 8 (22) | 1.67 (0.71-3.91) | 0.23 | Â | Â |
Armitages’ trend test | Common OR= 1.67 | 0.28 |  |  | ||
Significance level (P-value) for deviation from HWE | 0.03 | 0.88 | ||||
TP53 (p53) codon 72 G>C Arg/Pro (rs1042522) | ||||||
Genotype | Â | Â | Â | Â | Â | Â |
G/G | 18 (22) | 2 (11) | Â | Â | 22.03 | 2.35 |
G/C | 49 (60) | 9 (50) | 0.61 (0.12-3.07) | 0.54 | 40.95 | 8.31 |
C/C | 15 (18) | 7 (39) | 0.24 (0.04-1.32) | 0.08 | 19.03 | 7.35 |
G/C+C/C | 64 (78) | 9 (89) | 0.44 (0.09-2.12) | 0.29 | Â | Â |
Allele | Â | Â | Â | Â | Â | Â |
G | 85 (52) | 13 (36) | Â | Â | Â | Â |
C | 79 (48) | 23 (64) | 0.53 (0.25-1.11) | 0.09 | Â | Â |
Armitages’ trend test: | Common OR= 0.48 | 0.06 |  |  | ||
Significance level (P-value) for deviation from HWE | 0.07 | 0.72 |